Global SWOT Analysis on Pneumonia Testing Market 2017 to 2021 March 2017

Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market
analysis with inputs from industry experts. This report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the key vendors operating
in this market.
Inquire for more information at
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=917435
The following companies are the key players in the global pneumonia testing market: Abbott
Molecular, bioMérieux, Becton, Dickenson and Company (BD), Roche Molecular Diagnostics, and
Thermo Fisher Scientific.
Other Prominent Vendors in the market are: AdvanDx, Alere, Beckman Coulter, Bio-Rad, Cepheid,
Concile, Diamedix, DiaSorin, Eiken Chemical, Fast-track diagnostics, Hologic, Meridian Biosciences,
Qiagen, Quest Diagnostics, Quidel, SeraCare, and Trinity Biotech.
This report covers the present scenario and the growth prospects of the global pneumonia testing
market for 2017-2021. To calculate the market size, the report considers the revenue generated
from the sales of various diagnostic tests for pneumonia (community-acquired pneumonia (CAP) and
hospital-acquired pneumonia (HAP)) to key end-users such as hospitals, diagnostic laboratories, and
homecare.
Purchase directly at http://www.reportsnreports.com/purchase.aspx?name=917435
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market
and vendor landscape in addition to a SWOT analysis of the key vendors.
According to the report, one driver in market is growing popularity of POC testing. POC testing is the
new boom in the market because of the decreased time latency between diagnosis and treatment.
The advances in POC technology have facilitated data storage, data sharing, and communication
with public health agencies. Performing these tests to screen infectious diseases extends the
applications of this technology to the community practice setting.
Inquire for discount at http://www.reportsnreports.com/contacts/discount.aspx?name=917435
One trend in market is increase in adoption of molecular diagnostic testing. Accurate and rapid
diagnosis of pneumonia reduces recovery time and healthcare expenditure to a significant extent.
Recent advances in molecular diagnostic testing technologies have led to an improvement in the
precision, sensitivity, efficiency, and speed of clinical diagnostic procedures. For instance, FilmArray
by bioMérieux offers fast, easy, and comprehensive molecular testing technology that integrates
sample preparation, amplification, detection, and analysis.
Further, the report states that one challenge in market is limited detection capability and accuracy.
Pneumonia testing, especially the rapid diagnostic kit, in many clinical trials has failed to provide
accurate results in comparison with detailed testing. One of the prime reasons for this is that
pneumonia can be caused either by bacteria, virus, or fungus.
About Us: